A New Jersey appeals panel has handed Merck & Co. a victory in mass litigation over its painkiller Vioxx by barring 98 English and Welsh users of the drug from suing in the state's courts. The plaintiffs wanted to take advantage of New Jersey's plaintiff-friendly laws and fee-switching rules that don't exist in the United Kingdom, the other possible forum. But the appeals court ruled that U.K. remedies are adequate and that New Jersey trials would be less convenient for the state's courts and the litigants.
August 01, 2007 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
A New Jersey appeals panel has handed Merck & Co. a victory in the mass litigation over its painkiller Vioxx by barring 98 English and Welsh users of the drug from suing in the state’s courts.
The plaintiffs wanted to take advantage of New Jersey’s plaintiff-friendly laws and fee-switching rules that do not exist in the United Kingdom, the other possible forum.
Presented by BigVoodoo
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Truly exceptional Bergen County New Jersey Law Firm is growing and seeks strong plaintiff's personal injury Attorney with 5-7 years plaintif...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
